about
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The...
Read More
30.15
-0.69
(-2.24%)
3.3M
XNAS Volume
XNAS 12 Nov, 2025 3:55 PM (EST)
Board Meeting
The board meeting for uniQure N.V. is scheduled for today, for the purpose of uniQure NV Third Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
uniQure NV Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..